Skip to main content

Table 3 General characteristics of kidney transplant recipients, for group 1, 2 and 3

From: Prevalence of vancomycin-resistant Enterococcus fecal colonization among kidney transplant patients

 

Group 1

Group 2

Group 3

Characteristic

VRE+

VRE -

p value

VRE+

VRE -

p value

VRE+

VRE -

p value

Gender

         

   Male

10(71.4)

58(65.9)

0.769

6(54.5)

35(56.5)

1

4(30.8)

50(54.3)

0.111

Ages, in years

43 ± 14

39 ± 13

0.579

40 ± 10

41 ± 13

0.857

41 ± 11

42 ± 10

0.789

Race

         

   White

11(78.6)

61(69.3)

 

7(63.6)

41(66.1)

 

12(92.3)

55(59.8)

 

   Non-white

3(21.4)

27(30.6)

0.494

7(63.6)

21(33.9)

0.791

1(7.7)

37(40.3)

0.122

Primary renal disease

         

   Indeterminate

8(57.1)

45(51.1)

 

6(54.5)

32(51.6)

 

7(53.8)

39(42.4)

 

   Hypertension

3(21.4)

17(19.3)

 

3(27.3)

16(25.8)

  

22(23.9)

 

   Glomerulonephritis

3(21.4)

15(17)

  

6(9.7)

 

3(23.1)

17(18.5)

 

   Diabetes Mellitus

 

4(4.5)

  

3(4.8)

 

1(7.7)

3(3.3)

 

   Others

 

7(8)

0.934

2(18.2)

5(8.1)

0.752

2(15.4)

11(12)

0.195

Pre transplant treatment

         

   Hemodialysis

13(92.9)

79(89.8)

 

11(100)

58(93.5)

 

10(76.9)

91(98.9)

 

   CAPD

 

7(8)

  

2(3.2)

 

2(15.4)

1(1.1)

 

   Conservative

1(7.1)

2(2.3)

0.269

 

2(3.2)

1

1(7.7)

 

0.006

Kidney donor

         

   HLA I and II

6(42.9)

55(62.5)

 

5(45.5)

36(58.1)

 

8(61.5)

50(54.3)

 

   HLA III and deceased donor

8(57.1)

33(37.5)

0.164

6(54.5)

26(41.9)

0.518

5(38.5)

42(45.7)

0.626

Surgical reexploration

1(7.1)

1(1.1)

0.257

1(9.1)

5(8.1)

1

2(15.4)

4(4.3)

0.16

Mycophenolate mofetil

   

3(27.3)

31(50)

0.164

4(30.8)

21(22.8)

0.504

OKT3/Thymoglobulin®

    

7(11.3)

0.585

 

6(6.5)

1

Methylprednisolone pulse

   

2(18.2)

20(32.3)

0.486

4(30.8)

32(34.8)

1

Pos-transplantation dialysis

4(28.6)

14(15.9)

0.265

 

13(21)

0.195

1(7.7)

14(15.2)

0.687

Length of hospitalization in days

7 ± 2

8 ± 5

0.714

18 ± 22

17 ± 15

0.617

31 ± 36

23 ± 20

0.223

Serology

         

   Hepatitis C virus

1(7.1)

7(8)

1

 

1(1.6)

1

4(30.8)

18(21.4)

0.462

   Hepatitis B virus

 

4(4.5)

1

 

1(1.6)

1

1(7.7)

1(1.2)

0.236

Antimicrobial drugs

   

7(63.6)

31(50)

0.519

10(76.9)

69(75)

1

Vancomycin

   

1(9.1)

1(1.6)

0.28

3(23.1)

6(6.5)

0.081

Ganciclovir

    

6(9.7)

0.582

2(15.4)

10(10.8)

0.642

  1. CAPD = chronic ambulatory peritoneal dialysis; HLA I = identical human leukocyte antigen;
  2. HLA II = haplo-identical human leukocyte antigen; HLA III = distinct human leukocyte antigen;
  3. Fisher and Student t tests were utilized for mean age and length of hospitalization;
  4. Values are expressed as mean ± SD or N (%).